ROME — Artificial intelligence-based screening systems can be key in making diabetic retinopathy screening more accessible, financially viable and effective in terms of outcomes, according to one specialist at the FLORetina-ICOOR meeting.
“We know what a big economic and clinical burden diabetic retinopathy and diabetes are. We expect by 2030 that worldwide about 400 million patients will have diabetes. And we know that about 85% of these individuals will develop diabetic retinopathy within 20 years,” Majda Hadziahmetovic, MD, said.
Health care systems worldwide report a low